E-Mail
IMAGE: From left: University of Illinois researchers Zeynep Madak-Erdogan, associate professor of nutrition; Rohit Bhargava, director of the Cancer Center; and Colleen Bushell, director of the Healthcare Innovation Program Office at. view more
Credit: University of Illinois.
URBANA, Ill. ¬- When agrochemical and pharmaceutical companies develop new products, they must test extensively for potential toxicity before obtaining regulatory approval. This testing usually involves lengthy and expensive animal studies.
A research team at University of Illinois has developed a gene biomarker identification technique that cuts the testing process down to a few days while maintaining a high level of accuracy.
by John Klyczek / December 14th, 2020
Five of the pharmaceutical companies developing COVID-19 vaccines through the USA’s Operation Warp Speed have paid out a total of nearly $6 billion to settle lawsuits charging them with fraud related to “off-label” marketing of atypical antipsychotics and antidepressants that were mandated through the Texas Medication Algorithm Project (TMAP), which evolved into President George W. Bush’s federal “New Freedom Commission on Mental Health.” AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Janssen Pharmaceutical, and Pfizer, which are currently funded with over $7 billion from Operation Warp Speed, financed the nationwide rollout of fraudulent TMAP algorithms in order to bilk Medicaid programs and other public revenues to pay for drugs like Risperdal, Seroquel, Geodon, Paxil, and Wellbutrin, causing serious side-effects, including death.